EichorEICHOR
Study identifier: NCT07348263 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

EFESO: Study on Juvenile Onset Eosinophilic Fasciitis

Condition: Eosinophilic Fasciitis  ·  Sponsor: Meyer Children's Hospital IRCCS

PhaseN/A
Planned participants20
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

Eosinophilic fasciitis is a connective tissue disorder characterized by inflammation of the muscle fasciae, which is very rare in children. In juvenile-onset eosinophilic fasciitis (JEF), there may be severe joint involvement and skin manifestations may be less prevalent than in adults. It represents an important differential diagnosis of both juvenile-onset systemic sclerosis and localized scleroderma, and the correct classification of these patients is necessary to define a targeted diagnostic-therapeutic pathway. The diagnostic criteria proposed for eosinophilic fasciitis in the adult population do not necessarily require confirmation by skin biopsy, currently the "gold standard," which is an invasive procedure for pediatric patients; however, these criteria have never been directly applied to the pediatric population. From a therapeutic point of view, the combination of glucocorticoids and methotrexate is recommended for both adults and pediatric patients, but the data supporting this treatment in children are very limited, and there are no studies comparing the therapeutic approaches currently in use in pediatrics. Finally, there are no studies in the literature documenting the long-term prognosis of these patients in terms of functional limitations, quality of life, or complications related to the disease or treatments.

This description comes directly from the study's public registry record.

Talk to the study team

Edoardo Marrani  ·  +390555662913  ·  edoardo.marrani@meyer.it

Always discuss trial participation with your own doctor first.

Locations (15)

University of Alabama at BirminghamBirmingham, Alabama, United StatesRecruiting
SUNY Upstate Pediatric RheumatologySyracuse, New York, United StatesRecruiting
Children's Hospital ZagrebZagreb, CroatiaRecruiting
Hamburger Zentrum für Kinder- und Jugendrheumatologie -Hamburg, GermanyNot Yet Recruiting
Ruth Rappaport Children's Hospital of HaifaHaifa, IsraelNot Yet Recruiting
Meyer Children's Hospital IRCCSFlorence, FI, ItalyRecruiting
IRCCS Giannina Gaslini,Genova, ItalyRecruiting
Università di UdineUdine, ItalyNot Yet Recruiting
Iuliu Hatieganu University of Medicine and PharmacyCluj-Napoca, RomaniaRecruiting
University Children's HospitalLjubljana, SloveniaNot Yet Recruiting
Hospital Sant Joan de Déu,Barcelona, SpainNot Yet Recruiting
Astrid Lindgren Children's HospitalSolna, Stockholm County, SwedenRecruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →